FI871206A - 2-azolylmetyl-2-aryl-1,3-dioxolaner och deras salter, foerfaranden foer deras framstaellning, dessa innehaollande medel och deras anvaendning. - Google Patents

2-azolylmetyl-2-aryl-1,3-dioxolaner och deras salter, foerfaranden foer deras framstaellning, dessa innehaollande medel och deras anvaendning. Download PDF

Info

Publication number
FI871206A
FI871206A FI871206A FI871206A FI871206A FI 871206 A FI871206 A FI 871206A FI 871206 A FI871206 A FI 871206A FI 871206 A FI871206 A FI 871206A FI 871206 A FI871206 A FI 871206A
Authority
FI
Finland
Prior art keywords
dioxolaner
foerfaranden
azolylmethyl
salter
framstaellning
Prior art date
Application number
FI871206A
Other languages
English (en)
Finnish (fi)
Other versions
FI871206A0 (fi
Inventor
Klaus-Dieter Kampe
Wolfgang Raether
Walter Dittmar
Heinz Haenel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI871206A0 publication Critical patent/FI871206A0/fi
Publication of FI871206A publication Critical patent/FI871206A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/60—1,4-Diazines; Hydrogenated 1,4-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI871206A 1986-03-21 1987-03-19 2-azolylmetyl-2-aryl-1,3-dioxolaner och deras salter, foerfaranden foer deras framstaellning, dessa innehaollande medel och deras anvaendning. FI871206A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863609598 DE3609598A1 (de) 1986-03-21 1986-03-21 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Publications (2)

Publication Number Publication Date
FI871206A0 FI871206A0 (fi) 1987-03-19
FI871206A true FI871206A (fi) 1987-09-22

Family

ID=6296970

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871206A FI871206A (fi) 1986-03-21 1987-03-19 2-azolylmetyl-2-aryl-1,3-dioxolaner och deras salter, foerfaranden foer deras framstaellning, dessa innehaollande medel och deras anvaendning.

Country Status (14)

Country Link
US (1) US4859670A (ko)
EP (1) EP0237962A3 (ko)
JP (1) JPS62230781A (ko)
KR (1) KR870008873A (ko)
AU (1) AU590692B2 (ko)
CA (1) CA1294280C (ko)
DE (1) DE3609598A1 (ko)
DK (1) DK144087A (ko)
FI (1) FI871206A (ko)
HU (1) HUT48236A (ko)
IL (1) IL81950A (ko)
NO (1) NO871165L (ko)
PT (1) PT84530B (ko)
ZA (1) ZA872021B (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609596A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3609597A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
EP0296518A1 (de) * 1987-06-22 1988-12-28 Ciba-Geigy Ag Neue Phenylether-derivate als Mikrobizide, Verfahren zu deren Herstellung und deren Verwendung
US5120718A (en) * 1991-06-13 1992-06-09 Abbott Laboratories Candida acid protease inhibiting compounds
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
US5594141A (en) 1994-11-23 1997-01-14 Neurogen Corporation Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
CA2205969A1 (en) * 1994-11-23 1996-05-30 Neurogen Corporation Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
CA2269608A1 (en) 1996-11-12 1998-05-22 Sepracor Inc. 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
WO1998021213A2 (en) * 1996-11-12 1998-05-22 Sepracor, Inc. 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
US5945421A (en) * 1997-08-11 1999-08-31 Warner-Lambert Company Dopamine D4 receptor antagonists
US6147077A (en) * 1999-04-29 2000-11-14 Sepracor Inc. 2R,4S-hydroxyitraconazole isomers
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
CA2475879A1 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Synthesis of quinazolinones
JP2005530785A (ja) 2002-05-09 2005-10-13 サイトキネティクス・インコーポレーテッド 化合物、組成物、及び方法
CA2485148A1 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
US7038048B2 (en) * 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
CA2489367A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
EP1537089A4 (en) * 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JP2006501306A (ja) * 2002-09-30 2006-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
EP1594849A4 (en) * 2003-01-17 2007-07-04 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
EP1682534A2 (en) * 2003-11-03 2006-07-26 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions, and methods
US20050148593A1 (en) * 2003-11-07 2005-07-07 Gustave Bergnes Compounds, compositions, and methods
US8455489B2 (en) * 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
US7439254B2 (en) * 2003-12-08 2008-10-21 Cytokinetics, Inc. Compounds, compositions, and methods
BR102012024778A2 (pt) * 2012-09-28 2014-08-19 Cristalia Prod Quimicos Farm Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
KR102579848B1 (ko) * 2014-12-05 2023-09-18 풀모사이드 리미티드 항진균 화합물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4287195A (en) * 1978-07-14 1981-09-01 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
US4456605A (en) * 1981-05-07 1984-06-26 Janssen Pharmaceutica N.V. Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
FI834141A (fi) * 1982-11-16 1984-05-17 Ciba Geigy Ag Foerfarande foer framstaellning av nya arylfenyleterderivat.
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
DE3404819A1 (de) * 1984-02-10 1985-08-14 Ludwig Heumann & Co GmbH, 8500 Nürnberg Neue 1,3-dioxolanylderivate, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltendes arzneimittel
DE3410070A1 (de) * 1984-03-20 1985-10-03 Hoechst Ag, 6230 Frankfurt 1-(2-aryl-1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung, sie enthaltende zubereitungen und ihre verwendung
DE3609597A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
DE3609596A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
ZA872021B (en) 1987-09-10
US4859670A (en) 1989-08-22
AU7042287A (en) 1987-09-24
PT84530A (de) 1987-04-01
EP0237962A2 (de) 1987-09-23
NO871165L (no) 1987-09-22
EP0237962A3 (de) 1989-03-22
FI871206A0 (fi) 1987-03-19
AU590692B2 (en) 1989-11-09
DK144087A (da) 1987-09-22
HUT48236A (en) 1989-05-29
KR870008873A (ko) 1987-10-21
PT84530B (pt) 1989-11-10
IL81950A (en) 1991-06-30
DK144087D0 (da) 1987-03-20
IL81950A0 (en) 1987-10-20
CA1294280C (en) 1992-01-14
DE3609598A1 (de) 1987-10-01
JPS62230781A (ja) 1987-10-09
NO871165D0 (no) 1987-03-20

Similar Documents

Publication Publication Date Title
FI871206A (fi) 2-azolylmetyl-2-aryl-1,3-dioxolaner och deras salter, foerfaranden foer deras framstaellning, dessa innehaollande medel och deras anvaendning.
FI873509A (fi) Imidazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI865369A (fi) N-innehaollande fusionerade heterocykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI871828A (fi) Substituerade benzamidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI922277A (fi) Icke-replicerande, medelst rekombinant-teknik framstaellda retrovirala partiklar, vilka anvaendes som antivirala medel och immunogener.
FI871719A0 (fi) Tiolaktam-n-aettiksyraderivat, deras framstaellning och anvaendning.
FI884505A (fi) Immunoanalys, i vilken anvaends igg-uppsnappande antikroppar och detekteringssystem foer flera monoklonala antikroppar.
FI863795A0 (fi) Arylmetylazoler och deras salter, foerfarande foer deras framstaellning och dessa innehaollande aemnen samt deras anvaendning.
FI870342A (fi) Aminderivator, foerfarande foer deras framstaellning och deras anvaendning.
FI874548A0 (fi) Hydroxikarboxylsyraderivat, foerfarande foer deras framstaellning och deras anvaendning i tryck- eller vaermekaensliga maerkmaterial.
FI871207A (fi) 2-azolylmetyl-2-aryl-1,3-dioxolaner och deras salter, foerfaranden foer deras framstaellning, dessa innehaollande medel och deras anvaendning.
FI871953A0 (fi) Papperslimaemnen, deras framstaellning och anvaendning.
FI874470A (fi) Antracyklin-glykosider med antitumoeraktivitet, deras framstaellning, mellanprodukter daerav och kompositioner och anvaendning daerav.
FI892207A0 (fi) 2-adamantyl-4-isotiazolin-3-oner, deras tillverkningsfoerfarande och anvaendning som baktericida och fungicida medel.
FI871813A0 (fi) Benzodiazepinderivat, deras framstaellningsfoerfarande och dessa innehaollande laekemedel och deras anvaendning.
FI875164A (fi) Hartsbelagda, icke-absorberande, kornformiga, pesticidhaltiga kompositioner och foerfarande foer deras framstaellning.
FI853663A0 (fi) Framstaellningsfoerfarande foer 8-halogen-5,6-dialkoxikinazolin-2,4-dioner och deras salter.
FI873081A (fi) Pulverformigt lack, dess framstaellning och anvaendning.
FI873080A (fi) Pulverformigt lack, dess framstaellning och anvaendning.
FI875720A (fi) Imidazolderivat, foerfarande foer deras framstaellning och deras anvaendning saosom antimykotiska medel.
FI875509A0 (fi) Oxadiazolonderivat, foerfarande foer framstaellning daerav och herbicid innehaollande detsamma.
FI865295A0 (fi) Azoniaspironortropanolester, foerfarande foer dess framstaellning och farmaceutiskt medel.
FI851756L (fi) N,3-disubstituerade 2-oxindol-1 -karboxiamider saosom smaertstillande och antiinflammatoriska medel.
FI864378A0 (fi) 5-heterocyklo-2,4-dialkyl-3h,1,2,4 -triazol-3-tioner och deras anvaendning som antidepressanter.
FI890974A0 (fi) Funktionella kronetrar, foerfarande foer deras framstaellning och deras anvaendning som komplexbildande medel foer joner.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: HOECHST AKTIENGESELLSCHAFT